Insider filing · BSX

Michael F Mahoney bought $9.0M of Boston Scientific (BSX)

Executed Aug 3, disclosed Aug 5, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Aug 5), the stock returned -2.2% (delay-adjusted); from the execution session (Aug 3), +1.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

MM Michael F Mahoney Director profile →

Michael F Mahoney (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Boston Scientific Corporation (BSX). Across 1 priced purchase filing, the average 21-session return was +1.0% from execution and -2.2% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of BSX (160,901 sh across 2 lots, as filed), executed Feb 2.

BSX Boston Scientific Corporation BSX · Healthcare · 83 filings in 24 months ticker →

Healthcare · Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties wor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→